• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device real time nucleic acid amplification system
Regulation Description Instrumentation for clinical multiplex test systems.
Definition The system is a clinical multiplex instrument intended to measure and sort multiple signals generated my multiple probes, intercalating dyes, or other ligands in an assay from a clinical sample. Signals may be generated by fluorescence or other phenomena and may be measured using filters on a photodiode or other detector. It may integrate sample and/or reagent handling, amplification, dedicated instrument control, data acquisition software, raw data storage mechanisms and other essential hardware components along with the signal reader unit. The system is used with specific assays to comprise an assay test system.
Product CodeOOI
Regulation Number 862.2570
Device Class 2


Premarket Reviews
ManufacturerDecision
MERIDIAN BIOSCIENCE, INC
  SUBSTANTIALLY EQUIVALENT 2
MERIDIAN BIOSCIENCE, INC.
  SUBSTANTIALLY EQUIVALENT 1

MDR Year MDR Reports MDR Events
2020 134 134
2021 324 324
2022 874 874
2023 223 223
2024 329 330
2025 117 117

Device Problems MDRs with this Device Problem Events in those MDRs
False Positive Result 742 742
Program or Algorithm Execution Problem 316 316
Incorrect, Inadequate or Imprecise Result or Readings 301 301
Device Dislodged or Dislocated 194 194
Fluid/Blood Leak 185 185
False Negative Result 60 60
Unable to Obtain Readings 56 57
Mechanical Problem 53 53
Structural Problem 39 39
Smoking 21 21
No Apparent Adverse Event 16 16
Human-Device Interface Problem 9 9
Sparking 7 7
Temperature Problem 6 6
Detachment of Device or Device Component 5 5
Leak/Splash 4 4
Adverse Event Without Identified Device or Use Problem 4 4
Patient Data Problem 4 4
Failure to Obtain Sample 3 3
Unintended Electrical Shock 3 3
Fire 3 3
Device Fell 2 2
Non Reproducible Results 2 2
Output Problem 2 2
Overheating of Device 2 2
Difficult to Open or Close 2 2
Insufficient Information 1 1
Unintended Movement 1 1
Defective Component 1 1
Therapeutic or Diagnostic Output Failure 1 1
Ejection Problem 1 1
Device Markings/Labelling Problem 1 1
Crack 1 1
Failure to Power Up 1 1
Use of Device Problem 1 1
Thermal Decomposition of Device 1 1
Device Damaged by Another Device 1 1
Data Problem 1 1
Physical Resistance/Sticking 1 1
Volume Accuracy Problem 1 1
Device Emits Odor 1 1
Low Readings 1 1
No Display/Image 1 1
Melted 1 1
Nonstandard Device 1 1
Electrical /Electronic Property Problem 1 1
Improper or Incorrect Procedure or Method 1 1
Mechanical Jam 1 1
Device Ingredient or Reagent Problem 1 1
Fumes or Vapors 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Clinical Signs, Symptoms or Conditions 1884 1885
No Consequences Or Impact To Patient 108 108
No Known Impact Or Consequence To Patient 18 18
No Patient Involvement 17 17
Insufficient Information 9 9
Abrasion 6 6
Electric Shock 2 2
Test Result 2 2
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available 1 1
No Information 1 1
Head Injury 1 1
Pallor 1 1
Limb Fracture 1 1
Skin Tears 1 1
Bruise/Contusion 1 1

Recalls
Manufacturer Recall Class Date Posted
1 Abbott Molecular, Inc. II Apr-24-2025
2 Abbott Molecular, Inc. II Apr-19-2024
3 Abbott Molecular, Inc. III Feb-26-2024
4 Abbott Molecular, Inc. II Apr-06-2023
5 Abbott Molecular, Inc. II Jan-20-2023
6 Abbott Molecular, Inc. II Nov-18-2022
7 Abbott Molecular, Inc. II Mar-02-2022
8 Biocartis Nv II Jan-10-2025
9 DiaSorin Molecular LLC II Jul-18-2023
10 DiaSorin Molecular LLC II Jan-05-2022
11 Hologic, Inc. II Jan-23-2024
12 Luminex Corporation II May-13-2022
13 Luminex Corporation II Feb-02-2022
14 Luminex Corporation II Jan-14-2022
15 Meridian Bioscience Inc II Jul-28-2022
16 Meridian Bioscience Inc II Mar-30-2022
17 Qiagen Sciences LLC II Mar-12-2020
18 Roche Molecular Systems, Inc. II Mar-28-2022
-
-